included abnormally elevated renal parameters, signs of a concomitant infectious process (fever, leukocytosis, or a positive urine dipstick), pain poorly responding to analgesia, radiolucent stones, or stones smaller than 4-mm or larger than 15-mm in size. 72 patients had been randomly assigned to undergo ESWL directly without pre-stenting (Group A), while 52 patients were assigned for pre-stenting (Group B), with their data and outcomes prospectively collected. Mean patient BMI in both groups was 26.1 and 26.7 kg/m2 (p ¼ 0.49), mean skin-to-stone distance was 11 and 10.1 cm (p ¼ 0.03), mean stone size was 7.3 and 7.8 mm (p ¼ 0.114), and mean stone density was 902 and 1078 Hounsfield units (p ¼ 0.005) respectively. RESULTS: 72 patients had undergone emergency ESWL directly without pre-stenting (Group A), while 52 patients had undergone pre-stenting before emergency ESWL (Group B). All 124 patients had their first session of ESWL done within 48 hours of their initial presentation. 8 patients were lost to follow up in Group A, while one patient was lost to follow up in Group B. Four patients' stones had migrated to the kidney with stenting and were excluded from the study. Stone clearance in both groups was 61% and 44% (p ¼ 0.068) after one session, 91% vs 59% (p ¼ <0.001) by the second session, and 95% and 73% (p ¼ 0.001) by the third and last session. No patients in Group A crossed over to Group B or required stenting at any point.
INTRODUCTION AND OBJECTIVES: Obesity is increasingly common and often a predisposing factor in stone formation. Clinical reviews and guidelines indicate that SWL outcomes are poor for treating stones in patients with skin-to-stone distance (SSD) of >10-14cm, and regard a large SSD as an adverse predictor for SWL success (EAU Urolithiasis Guidelines 2016). There is a paucity of literature on treating such patients with SWL, and given the higher recognised perioperative morbidity of surgery in such a population, and the potential benefits of sedo-analgesia and short length of stay with ambulatory SWL, it is germane to re-evaluate the efficacy of SWL for treating such patients using a lithotriptor with a focal length of >14cm.
METHODS: Consecutive patients with a solitary radio-opaque upper ureteric calculus diagnosed on CT scan with a SSD !14cm were identified from a prospective database (2011) (2012) (2013) (2014) (2015) (2016) . Out-patient SWL was performed under sedo-analgesia (diclofenac AE alfentanil) using a Sonolith I-Sys, EDAP-TMS (focal depth 17cm). Outcome was assessed with an XRKUB at 2 weeks. Those with significant fragments (>3mm) received further treatment. Success was defined as patients being free of stones on XRKUB or as having asymptomatic clinically insignificant stone fragments (CISF) 3mm. Failure was defined as residual fragments >3mm (treated with ureteroscopy).
RESULTS: 182 patients met the inclusion criteria. 4 were lost to follow up. Median age was 54 years. Median stone size was 8mm (range 3-21). Overall stone-free rate (SFR) was 81% after mean 1.3 sessions. 63% were stone-free after a single session. 9% had CISF 3mm. 11% required ureteroscopy.
CONCLUSIONS: SWL can provide efficacious treatment of upper ureteric stones in obese patients, traditionally thought to be poor candidates for such treatment due to their high SSD. The upper threshold of SSD for SWL selection should be revised, as such patients can receive the benefits of effective SWL treatment, without the need for general anaesthesia, when referred to a dedicated stone centre. 
Source of

INTRODUCTION AND OBJECTIVES:
We analyzed the effects of music on pain, anxiety and overall satisfaction in patients undergoing shock wave lithotripsy (SWL) procedure.
METHODS: Two hundred patients scheduled for SWL were prospectively enrolled in this study. Group 1 consisted of 95 patients who listened music during the SWL procedure while 105 patients in group 2 did not listen music during the treatment. Anxiety of the patients were measured according to State-Trait Anxiety Inventory (STAI). STAI-T (Trait) was completed only before the procedure, whereas STAI-S (State) was completed both before and after SWL. Pain, patient satisfaction and willingness to repeat procedure were evaluated after SWL using a visual analog scale (VAS). Hemodynamic parameters including sistolic blood pressure (SBP), diastolic blood pressure (DBP) and heart rate (HR) were measured before and after procedure.
RESULTS: Group 1 consisted of 95 (47.5%) patients while group 2 included 105 (52.5%) patients. No statistically significant difference was found between two groups in terms of stone characteristics, SWL parameters, STAI-T and STAI-S scores and hemodynamic parameters before SWL. Pre-SWL hemodynamic parameters, STAI-S and STAI-T scores of the study groups are displayed in Table 1 . After SWL completed, STAI-S scores were found to be lower in patients who listened music (p¼0.006). At the end of the SWL, VAS scores of pain, satisfaction and willingness to repeat procedure were significantly different in favour of music group (p¼0.007, p¼0.001, p¼0.015, respectively). SBP, DBP and HR were found significantly higher in patients who did not listened music (p¼0.002, p¼0.024, p<0.001, respectively). Post-SWL hemodynamic parameters, STAI-S scores and VAS scores are shown in Table 2 .
CONCLUSIONS: Music can be an ideal adjunctive treatment modality for patients undergoing SWL treatment. It has the potential to enhance patient compliance and treatment satisfaction by reducing the procedure-related anxiety and pain perception. Vol. 197, No. 4S, Supplement, Sunday, May 14, 2017 THE JOURNAL OF UROLOGY â e833
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There is clinical equipoise as to the most cost effective approach for the treatment of lower pole stones between 10-20mm. We aimed to assess the clinical features, outcomes, complications, and cost-effectiveness of ambulatory SWL, FURS and PCNL in the treatment of lower pole (LP) stones (10-20mm) in a large tertiary referral stone centre.
METHODS: Consecutive patients treated for solitary LP stones (10-20mm) between 2008-13 were identified from a prospective database. Ambulatory SWL under sedo-analgesia (diclofenac +/-alfentanyl) was used as primary treatment in all cases (following a stone MDT assessment), with FURS and PCNL reserved for SWL contraindications, failure or patient choice. "Success" was defined as stone free and/or clinically insignificant stone fragments (¼3mm) at 1 and 3 months follow-up. Effect of anatomy on SWL success was determined from using CT images and regression analysis. Average cost per treatment modality (including additional second-line treatments) was calculated using the NHS England 2014/15 National Tariff HRG codes.
RESULTS: 225 patients were included (mean age 54.9; median stone size 12mm). 198 (88%), 21 (9.3%) and 6 (2.7%) patients underwent SWL, FURS and PCNL as primary treatments respectively; for median stone sizes of 12mm, 12mm, and 20mm. Overall success rates were 82.8%, 76.1% and 66.7% respectively (p < 0.05). 63% of patients undergoing primary SWL were successfully treated after one session. Anatomical analysis determined infundibulopelvic angle and infundibular length to be significantly different in patients successfully treated with SWL (p ¼ 0.04. SWL was performed with superior length of stay and complication rates compared to FURS or PCNL (p<05), and with a low auxiliary treatment rate (7%). SWL was significantly more cost-effective (mean £751/patient) than FURS (mean £1261) or PCNL (mean £2658) (p < 0.01).
CONCLUSIONS: SWL is a cost-effective, and efficacious primary treatment for patients with solitary LP stones (10-20mm). The majority of patients can be successfully treated with primary SWL in a dedicated stone centre, with the benefits of a short length of stay, low complication and auxiliary treatment rates, and without the need for general anaesthesia. The referral of such patients to high-volume lithotripsy centres with demonstrable outcomes should be given due consideration.
Source of Funding: None
MP62-19 CROSS VALIDATION OF A PREDICTIVE ANALYTIC MODEL WHICH PREDICTS SUCCESS AND COMPLICATIONS OF SHOCKWAVE LITHOTRIPSY
Blake Hamilton*, Salt Lake City, UT; Ryan Seltzer, Donald Gleason, Tucson, AZ; Stephen Nakada, Madison, WI; Glenn Gerber, Chicago, IL INTRODUCTION AND OBJECTIVES: Shockwave lithotripsy (SWL) is a primary treatment for nephrolithiasis that has been used widely for the past 3 decades. Recently, this technology has come under fire because of declining outcomes in the face of improving alternative technologies. Multiple authors have described pre-operative parameters that improve the success of SWL, including stone size, location, density, and skin-to-stone distance. Using these and other parameters, we present a predictive analytic model to help urologists select the most effective treatment modality with the highest likelihood of success and lowest likelihood of complication.
METHODS: We performed a random 70/30 split of 7,000 SWL treatment records for renal and ureteral stones from 2010-2016 to train and validate a generalized linear mixed model (GLMM) using statistical software (PROC GLIMMIX in SAS 9.4). This model uses 9 parameters: stone size, Hounsfield Units (HU), body mass index (BMI), stone location, anesthesia type, SWL machine type, anticoagulant use, age, and gender to predict treatment success, defined as stone free or fragments ¼ 4mm, and to predict treatment complications. Actual treatment success and complications were obtained from self-reported physician follow-up surveys tied to the original SWL treatment record. Both treatment and follow-up data are housed in The Stone Disease Registry.
RESULTS: The training model was significantly related to treatment success, Likelihood Ratio (LR) Chi-square ¼ 1136.02, p < .0001, Area under the curve (AUC) ¼ .82. This model was in turn a good predictor of success in the validation dataset, AUC ¼ .81. The training model was also significantly related to complications, Likelihood Ratio Chi-square ¼ 538.75, p < .0001, AUC ¼ .91. This model was a fair predictor of complication rate in the validation dataset, AUC ¼ .77.
CONCLUSIONS: This novel predictive analytic model provides accurate prediction of treatment success and complications for SWL. Given the robust model fit to the validation data, we conclude that this model will be useful in prospectively predicting success for the treatment of urinary stones with SWL. This has the potential to assist urologists in prospectively making evidence-based decisions on which treatment modality will be most effective in maximizing success and minimizing complications and costs for treatment of urinary stones.
